ライフサイエンスコーパス: blood transfusion

1 , central line, intracranial hemorrhage, and blood transfusion).

2 cesarean section requires donor (allogeneic) blood transfusion.

3 eding requiring treatment and postprocedural blood transfusion.

4 ng the higher (7 d) primaquine dose required blood transfusion.

5 surements: Patients were followed from first blood transfusion.

6 Initial postoperative blood transfusion.

7 ient with ribavirin-related anemia requiring blood transfusion.

8 all preprocedure hemoglobin levels versus no blood transfusion.

9 ts (27.5%) received at least 1 postoperative blood transfusion.

10 243 (4.6%) patients received a postoperative blood transfusion.

11 ad grade IV thrombocytopenia but required no blood transfusion.

12 disease (TA-GVHD) is a rare complication of blood transfusion.

13 COVID-19 pandemic has major implications for blood transfusion.

14 typing of blood groups is essential prior to blood transfusion.

15 understanding the risk of prion infection by blood transfusion.

16 required erythropoietin; no patient required blood transfusion.

17 ion against transmission of prion disease by blood transfusion.

18 re similar in age, injury severity, and 24hr blood transfusion.

19 at preventing transmission of the disease by blood transfusion.

20 Most (79%) required blood transfusion.

21 ction in this population are breast milk and blood transfusion.

22 ceding 3 months or because they had a recent blood transfusion.

23 ne of the leading causes of death related to blood transfusion.

24 ital with capacity for emergency surgery and blood transfusion.

25 gastrointestinal tract, 26 of whom required blood transfusion.

26 8513 (32.8%) patients received a blood transfusion.

27 had hematocrit reductions to <23% requiring blood transfusion.

28 n 78% of days; and 68% received at least one blood transfusion.

29 nd treat anemia and the reemergence of whole blood transfusion.

30 ute respiratory distress within 6 hours upon blood transfusion.

31 ratory distress that occur within 6 hours of blood transfusion.

32 ys, and the proportion of patients receiving blood transfusion.

33 , heart, lung, and stem-cell transplant, and blood transfusion.

34 a donor and an intended recipient prior to a blood transfusion.

35 Patients were followed from first blood transfusion.

36 , and is confounded by potential concomitant blood transfusion.

37 high serum ERFE levels, which decrease after blood transfusion.

38 ough previous transplantation, pregnancy, or blood transfusion.

39 in the development of lung injury following blood transfusion.

40 ine of incurable diseases, immunotherapy and blood transfusions.

41 timated blood loss, fluid resuscitation, and blood transfusions.

42 opathy in cardiac surgery and thereby reduce blood transfusions.

43 transfusion, and estimated cost of excessive blood transfusions.

44 ocytic leukemia (CLL) is transmitted through blood transfusions.

45 avenous fluids, vasopressors, inotropes, and blood transfusions.

46 Overall, 217 patients (54.1%) received blood transfusions.

47 high-risk blunt trauma patients who received blood transfusions.

48 malaria and sickle cell anemia, or following blood transfusions.

49 life as well as increased risk of allogeneic blood transfusions.

50 vious injections and 40 (9%) of 453 reported blood transfusions.

51 ent trauma patients who subsequently require blood transfusions.

52 ibutable to mother-to-child transmission and blood transfusions.

53 ent Intervention Triage) and requirement for blood transfusions.

54 d no difference in the rate of perioperative blood transfusion (1 patient [2%] for LH vs 5 [10%] for

55 idence interval [CI] 3.9-13.9, p < 0.001), a blood transfusion (1.14%, n = 324 versus 0.50%, n = 226,

56 No significant difference was seen with blood transfusion (10.4% versus 10.8%; P=0.70), gastroin

57 implantation (2.9% versus 8.0%; P<0.001) and blood transfusion (12.8% versus 22.9%; P<0.001).

58 virin requiring its dose reduction (28%) and blood transfusion (15.7%) were associated with more rela

59 uded plasmapheresis (18), chemotherapy (30), blood transfusions (2), transplantation of progenitor he

60 sed injection drug, 33.3% who had history of blood transfusion, 29.8% who had sexual experience, 21.2

61 Patients with anemia received >/=1 blood transfusion 2x more often, but the indication of t

62 ey injury (20.8% vs 13.8%, P < .001), 30-day blood transfusion (3.4% vs 2.7%, P < .01), and 1-year re

63 major bleeding (14.0% versus 0.9%; P<0.001), blood transfusion (3.7% versus 0.2%; P<0.001), and death

64 anemia (3.2% compared with 16.4%; P < 0.05), blood transfusion (4.5% compared with 16.4%; P < 0.05),

65 0.007), and a higher need for postoperative blood transfusion (4/14 vs 2/30, P = 0.071).

66 ; HR: 1.00; 95% CI: 0.50 to 1.99; p = 0.99), blood transfusions (4.8% vs. 4.5%; HR: 1.09; 95% CI: 0.5

67 4.0% vs 5.5%, P < 0.0001), require a massive blood transfusion (43.5% vs 1.1%, P < 0.0001), or requir

68 7]; P < .001), and casualties who received a blood transfusion (50.2% [618 of 1231] vs 3.7% [121 of 3

69 P = 0.03), less likelihood of intraoperative blood transfusion (52% vs 78%, P < 0.01), and less likel

70 for those critically injured who received a blood transfusion (6.8% [40 of 589] vs 51.0% [249 of 488

71 associated with a greater risk of requiring blood transfusion (7 studies in cardiac surgery, totalin

72 jor bleeding (15.3% versus 55.6%; P<0.0001), blood transfusions (9.2% versus 43.2%; P<0.0001), and ac

73 of betaT is a lifelong dependence on regular blood transfusions, a consequence of which is systemic i

74 ses the risk of blood transfusion allogeneic blood transfusion (ABT).

75 of this study was to examine variability in blood transfusions across hospitals and the relationship

76 s, and suggests that national transplant and blood transfusion agencies work together to develop a co

77 ver if left untreated, increases the risk of blood transfusion allogeneic blood transfusion (ABT).

78 ith a significant decreased risk of post-PCI blood transfusion among higher volume r-PCI sites.

79 After adjusting for cofactors such as blood transfusion and allograft nephrectomy, prolonged i

80 s with severe sepsis, and was increased with blood transfusion and among nonsurvivors of sepsis.

81 Blood transfusion and breast milk feeding.

82 dt-Jakob disease (vCJD) has occurred through blood transfusion and could also theoretically occur as

83 ory distress syndrome, low Hemoglobin level, blood transfusion and days on oxygen supplements with ei

84 ditive effect with those who both received a blood transfusion and developed sepsis having even worse

85 ly arising in older patients; in most cases, blood transfusion and hospitalization are required.

86 cross hospitals and the relationship between blood transfusion and in-hospital mortality in a large,

87 In a large study population, blood transfusion and mechanical ventilation were the on

88 ly, RARP led to a lower risk of experiencing blood transfusion and of having a pLOS (all P < .001).

89 the disease may also be transmitted through blood transfusion and perinatally.

90 nvestigate the potential additive effects of blood transfusion and sepsis on colon cancer disease-spe

91 hough RARP was associated with lower risk of blood transfusions and a slightly shorter length of stay

92 hospital stay, costs of warming blanket use, blood transfusions and antibiotics used in the operating

93 yndrome of respiratory distress triggered by blood transfusions and is the leading cause of transfusi

94 directed hemodynamic therapy, and minimizing blood transfusion), and treatment (early initiation of r

95 quired HCV through either injecting drugs or blood transfusion, and (3) an estimated date of acquirin

96 on rates, 30-day acute kidney injury, 30-day blood transfusion, and 1-year readmission rates for myoc

97 Safety outcomes included major bleeding, blood transfusion, and hospitalization for bleeding.

98 f perioperative IV iron reduces the need for blood transfusion, and is associated with a shorter hosp

99 ine the association between PCI access site, blood transfusion, and mortality.

100 spital stay and rates of pancreatic fistula, blood transfusion, and readmission were not statisticall

101 reactions, 3 had minor bleeding, 6 required blood transfusions, and 3 had life-threatening bleeding.

102 For ongoing therapies, hemodialysis, blood transfusions, and antibiotics were more likely to

103 ASA) >2, portal hypertension, intraoperative blood transfusions, and center's volume.

104 y would correct anaemia, reduce the need for blood transfusions, and improve patient outcomes.

105 rocedures (AOR = 1.41, p < 0.001), including blood transfusion (AOR = 4.7, p < 0.001); hospital admis

106 ational databases suggest that a restrictive blood transfusion approach is being increasingly impleme

107 ren with severe anemia and their response to blood transfusion are limited.

108 Blood transfusions are allogeneic, and when given posttr

109 Blood transfusions are an important resource of every he

110 Perioperative blood transfusions are associated with infectious compli

111 Perioperative blood transfusions are associated with shorter survival,

112 No consensus exists on whether preoperative blood transfusions are beneficial in patients with sickl

113 esection in patients receiving perioperative blood transfusions are caused by the clinical circumstan

114 Blood transfusions are critically important in many medi

115 Blood transfusions are frequently given to patients with

116 , as the potentially harmful consequences of blood transfusions are increasingly being recognized, ef

117 Blood transfusions are life-saving therapies; however, t

118 Repeated blood transfusions are one of the major causes of iron o

119 Blood transfusions are the mainstay of stroke prevention

120 difying therapies, hydroxyurea and long-term blood transfusions, are available but underused.

121 We investigated blood transfusion as a possible source of organ donor in

122 ial infections and sepsis, and the amount of blood transfusion as source of free heme correlated with

123 The overall reduction observed in donor blood transfusion associated with the routine use of cel

124 support were similar among those assigned to blood transfusion at a higher hemoglobin threshold and t

125 r hemoglobin threshold and those assigned to blood transfusion at a lower threshold; the latter group

126 n, antithymocyte globulin induction therapy, blood transfusion at the transplantation procedure, high

127 , C-reactive protein, smoking, drinking, and blood transfusion before 1992.

128 (including injection drugs) and receipt of a blood transfusion before 1992; 49% of persons with HCV i

129 mitted with severe anaemia needing an urgent blood transfusion, but blood is often unavailable.

130 e III cancer, lymphovascular permeation, and blood transfusion, but not the operative approach, were

131 lood cells (RBCs) are needed for life-saving blood transfusions, but they undergo continuous degradat

132 Blood transfusion can be a lifesaving treatment for the

133 anial doppler (TCD) flow velocities, regular blood transfusions can effectively prevent primary strok

134 Sequential expansion of blood transfusion capability after 2012 to deployed mili

135 sepsis (chi (2) = 7.47; P = 0.006), multiple blood transfusions (chi (2) = 5.11; P = 0.02), and deliv

136 ickle cell anemia or thalassemia, history of blood transfusion, cocaine and other drug use; there was

137 eding event that required hospitalization, a blood transfusion, colonoscopy, surgery, or another inva

138 vs elective, type of surgery, intraoperative blood transfusion), comorbidities (chronic obstructive p

139 s of less than 1000 g, a strategy of liberal blood transfusions compared with restrictive transfusion

140 Blood transfusion costs were reduced by 40% with the use

141 ondary to prior pregnancies, transplants, or blood transfusions, creating difficulty finding compatib

142 ion of intravenous fluids, vasopressors, and blood transfusion decreases mortality among Zambian adul

143 Liberal blood transfusion did not affect mortality compared with

144 tal treatment with mechanical ventilation or blood transfusion did not cause the observed increase in

145 The stored blood transfusion did not result in significant changes

146 sion (HR: 1.02, 95% CI: 0.65-1.58, P=0.970), blood transfusions did not increase the risk of overall

147 rates the lack of XMRV transmission by whole-blood transfusion during the acute phase of infection.

148 nalyses on 39 patients who did not receive a blood transfusion during the study period, the baseline

149 s or pneumonia, more frequently had received blood transfusions during surgery, and received ventilat

150 and decreases the need for vasopressors and blood transfusions during the neonatal period.

151 te form having vastly improved with exchange blood transfusion (EBT).

152 with the greatest decrease in Hb level and 1 blood transfusion, followed by clinically insignificant

153 alassemia intermedia, which does not require blood transfusion for survival, hyperabsorption of iron

154 rary practice, a trend of less perioperative blood transfusions for oncologic abdominal surgery was o

155 ing mean arterial pressure (>/=65 mm Hg) and blood transfusion (for patients with a hemoglobin level

156 (such as aspiration, repeat misoprostol, and blood transfusion), frequency of continuing pregnancy, r

157 and Parkinson disease in patients receiving blood transfusions from donors who were later diagnosed

158 of blood transfusion or death, and number of blood transfusions from randomisation to 30 days postope

159 Need for blood transfusion had a pooled OR of 1.14 (0.31, 4.18).

160 Patients who received allogeneic blood transfusions had a higher incidence of nosocomial

161 Perioperative blood transfusion has been reported to have a negative i

162 variant Creutzfeldt-Jakob disease (vCJD) via blood transfusion have relied largely on data from roden

163 er-to-fetus transmission, sexual contact and blood transfusion, have also been observed(3-7).

164 associated with a decreased risk of post-PCI blood transfusion (hazard ratio, 0.4; 95% confidence int

165 Prevention of HCV infection through blood transfusion, HCV treatment and adequate iron chela

166 h direct percutaneous exposure to blood, via blood transfusions, health-care-related injections, and

167 24 h after delivery; death; requirement for blood transfusion; hemoglobin changes; and use of additi

168 clinical history of previous injections and blood transfusions, HIV disease stage, hepatitis B and h

169 or hospital admissions for crises, number of blood transfusions, hydroxyurea therapy, transcranial Do

170 critical to advancing hPSC technologies for blood transfusion, immunotherapy, and transplantation.

171 lar complications occurred in 7.0% of cases, blood transfusion in 17.5%, clinical stroke in 1.8%, and

172 saturation [tSo2]) before, during, and after blood transfusion in a cohort of children presenting to

173 as to assess the safety and efficacy of cord blood transfusion in children with severe anaemia.

174 The majority of patients undergoing blood transfusion in clinical practice cannot be matched

175 XMRV transmission was evaluated by whole-blood transfusion in rhesus macaques.

176 d severe anemia but only 60 (48.8%) received blood transfusion in the ED.

177 od products, the immunomodulatory effects of blood transfusion in this group are inadequately describ

178 ients, the use of erythropoietin in 54%, and blood transfusions in 12%.

179 were documented frequently (eg, more than 6 blood transfusions in 20% of all patients and relaparoto

180 actorial, a key barrier is limited access to blood transfusions in hospice programmes.

181 itted through a bite of an infected tick and blood transfusions in human.

182 the decision-making regarding perioperative blood transfusions in patients undergoing curative recta

183 There were 111 blood transfusions in the placebo group and 105 in the i

184 International Society of Blood Transfusion, International Haemovigilance Network,

185 cell anaemia (n = 27) not receiving monthly blood transfusions (interquartile range cerebral blood f

186 01270854) of adult trauma patients requiring blood transfusion, intubation, or operation within 60 mi

187 Blood transfusion is controversial for anemic patients w

188 Blood transfusion is fundamental in managing hematologic

189 ease, the suggested hemoglobin threshold for blood transfusion is less than 80 g/L, with a higher thr

190 Blood transfusion is one of the most common procedures i

191 Blood transfusion is one of the most frequently used the

192 Blood transfusion is strongly associated with AKI in pat

193 Blood transfusion is the most common procedure completed

194 untries, RCTs have demonstrated that regular blood transfusion is the optimal current therapy for sec

195 tries; however, the degree of unmet need for blood transfusions is often unknown.

196 parasite that can be transmitted by means of blood transfusion, is responsible for the majority of ca

197 dness and fatigue, or we do treat it through blood transfusions, leading to iron overload, which is a

198 hese findings do not support hypotheses that blood transfusion leads to long-term immunosuppression t

199 mong the 5334 patients without postoperative blood transfusion, lower nadir hematocrit was associated

200 nefits of r-PCI in terms of reduced post-PCI blood transfusions may be more pronounced at sites that

201 The restrictive group received fewer blood transfusions: mean 20.3 +/- 32.7 units, median = 8

202 Blood transfusion might affect long-term mortality by ch

203 Blood transfusion might benefit some patients with malar

204 laria chemotherapy, fluid support, and whole-blood transfusion, mimicking the standard of care for th

205 We therefore aimed to estimate the blood transfusion need and supply at national level to d

206 Whether perioperative blood transfusions negatively impact survival remains a

207 Death or blood transfusion occurred in 67 (28%) of the 237 patien

208 ies had an adjusted odds ratio for receiving blood transfusion of 1.93 (95% CI, 1.21-3.07) compared w

209 identified, of whom 5900 (30.0%) received a blood transfusion (of 13657 patients who underwent a pan

210 be probably or certainly caused by the cord blood transfusion (one-sided 97.5% CI 0-6.5).

211 points were risk of the composite outcome of blood transfusion or death, and number of blood transfus

212 ificant bleeding, including any preoperative blood transfusion or transfusion of greater than 4 units

213 it did not significantly change the rate of blood transfusions or occurrence of cardiac tamponade.

214 morbidity (odds ratio (OR) 0.73, P = 0.028), blood transfusion (OR 0.44, P = 0.001), and LOS (P = 0.0

215 1.44, 95% CI 1.09-1.91), and intraoperative blood transfusion (OR 1.45, 95% CI 1.15-1.83) were weak

216 ubes for pneumothorax (OR = 7.5; P < 0.001), blood transfusion (OR = 2; P = 0.03), pulmonary complica

217 46; 95% CI, .33-.66; P < .01) and history of blood transfusion (OR, 0.43; 95% CI, .22-.83; P = .01) w

218 ence interval [CI], 1.99-4.08; P < 0.01) and blood transfusion (OR, 1.97; 95% CI, 1.20-3.14; P = 0.01

219 rdial complications, hematoma or hemorrhage, blood transfusion, or cardiogenic shock.

220 percent of patients required erythropoietin, blood transfusions, or RBV dose reduction for anemia.

221 us catheter, administration of inotropes, or blood transfusions; or usual care.

222 pic DN decreased the need for intraoperative blood transfusion (P < 0.001) and reduced the incidence

223 were the Rockall score (p = 0.004), units of blood transfusion (p = 0.031), and no antibiotic prophyl

224 e, hepatic iron overload because of frequent blood transfusions; P<0.05 for both), whereas diastolic

225 mprove outcome, and we recommend an exchange blood transfusion policy for all patients on the transpl

226 differences in rate of severe PPH, need for blood transfusion, postpartum hemoglobin, change in hemo

227 spitals, there was considerable variation in blood transfusion practices, and receipt of transfusion

228 entified a priori, to compare rates of donor blood transfusion (primary outcome) and fetomaternal hae

229 pected, IDU (65.9% versus 17.8%; P < 0.001), blood transfusion prior to 1992 (22.3% versus 11.1%; P <

230 traditional HCV risk factors such as IDU and blood transfusion prior to 1992.

231 Postoperative complications, blood transfusions, prolonged length of stay (pLOS), rea

232 ressor-free days, ventilation-free days, and blood transfusion proportion.

233 Donor blood transfusion rate was 3.5% in the control group ver

234 vaso-occlusive crisis and hemolytic events, blood transfusion rate, school attendance, and blood cou

235 effects and potentially immunosuppression in blood transfusion recipients.

236 irected therapy using fluids, inotropes, and blood transfusion reduced 30-day major complications in

237 molytic anemia, infection, tissue injury, or blood transfusion releases the endogenous damage-associa

238 reduced graft survival were: intraoperative blood transfusions, reoperation, human leukocyte antigen

239 rdial fibrosis are associated with increased blood transfusion requirements, whereas left ventricular

240 by the pattern/severity of injury, including blood transfusion requirements.

241 Compared to component transfusion, whole blood transfusion results in faster resolution of shock,

242 ncluding proceedings of major conferences on blood transfusions), searching the Internet for hemovigi

243 t case reporting the sequence: DBA, multiple blood transfusions, secondary haemochromatosis, advanced

244 the association of perioperative allogeneic blood transfusion, sepsis, and 5-year colon cancer disea

245 s, Ministry of Health websites, and National Blood Transfusion Services data for specific indicators

246 carification, injection drug use, history of blood transfusion, sexual experience, shaving equipment

247 ialist); prompt neuro-imaging and an initial blood transfusion (simple followed immediately by an exc

248 Studies suggest that a restrictive blood transfusion strategy is equivalent to a liberal st

249 is needed to determine whether a restrictive blood transfusion strategy might improve PCI outcomes by

250 ron overload, even in the absence of chronic blood transfusion, suggesting the presence of >=1 erythr

251 Massive transfusion protocols for blood transfusion support are reviewed, including practi

252 Both cases required blood transfusion support to maintain their hemoglobin a

253 The International Society of Blood Transfusion, the International Haemovigilance Netw

254 ances requiring transfusions, not due to the blood transfusions themselves.

255 harge, defined as the absence of rebleeding, blood transfusion, therapeutic intervention, 28 day read

256 OP], STOP II) have demonstrated that regular blood transfusion therapy (typically monthly) achieves p

257 nd silent cerebral infarcts includes regular blood transfusion therapy and in selected cases, hematop

258 nial Doppler screening, coupled with regular blood transfusion therapy, has decreased the prevalence

259 Regular blood-transfusion therapy significantly reduced the inci

260 e lower among children who underwent regular blood-transfusion therapy than among those who received

261 Although liberal blood transfusion thresholds have not been beneficial fo

262 servative fluid management, and conservative blood transfusion thresholds.

263 ing from 140 to 190 mm Hg), anemia requiring blood transfusions, thrombocytopenia, and pneumonia.

264 ldhood, so she had been submitted to monthly blood transfusions throughout her life, leading to a hep

265 r liberal transfusion in which they received blood transfusion to maintain haemoglobin level at 100 g

266 s no evidence of virus transmission by whole-blood transfusion to naive monkeys based upon PCR analys

267 Additionally, blood transfusions to correct anaemia exposes children t

268 n with sickle cell anemia to receive regular blood transfusions (transfusion group) or standard care

269 on of Zika virus in semen, the potential for blood-transfusion transmission, mother-to-child transmis

270 Blood transfusion was administered to 195 women (2.5%).

271 Blood transfusion was administered to 27 (24%) patients

272 Among comparable patients, blood transfusion was associated with a lower risk of in

273 sity matching those with overlapping scores, blood transfusion was associated with a reduced risk of

274 Our findings suggest that whole blood transfusion was associated with improved survival

275 In patients with postoperative MI, blood transfusion was associated with lower mortality, f

276 /valine heterozygous individual infected via blood transfusion was reported, and we established that

277 Blood transfusion was utilized in 2.2% of patients.

278 te chest syndrome, splenic sequestration, or blood transfusion) was less frequent with hydroxyurea (4

279 May 20, 2008, 413 children needing an urgent blood transfusion were admitted to Kilifi District Hospi

280 h weight, </= 1500 g) who had not received a blood transfusion were enrolled, with their mothers (n =

281 avenous fluids, vasopressors, inotropes, and blood transfusions were adjusted to reach central hemody

282 In unadjusted analysis, blood transfusions were associated with a 119% increased

283 ts who did and did not receive perioperative blood transfusions were compared using Cox regression an

284 sion (HR: 0.86, 95% CI: 0.60-1.23, P=0.672), blood transfusions were not associated with an increased

285 No blood transfusions were performed.

286 Hemodialysis, vasopressors, and blood transfusions were the interventions more likely to

287 ronous-major-procedure, inflow-occlusion and blood-transfusion were independent predictors of LCT-EOS

288 s not superior to placebo to reduce need for blood transfusion when administered to patients with ana

289 strictive transfusion in which they received blood transfusion when haemoglobin level was lower than

290 erative and postoperative complications, and blood transfusion when undergoing a hysterectomy later i

291 a, such as in thalassaemia, require repeated blood transfusions, which leads to iron overload and cel

292 Blood transfusion (whole blood at a target volume of 20

293 reduced consciousness) to receive immediate blood transfusion with 20 ml per kilogram or 30 ml per k

294 ontributes to the ultimate goal of replacing blood transfusion with a manufactured product.

295 no studies have evaluated the association of blood transfusion with AKI in patients undergoing PCI.

296 cardiac tamponade; nonbypass surgery-related blood transfusion with preprocedure hemoglobin >/= 8 g/d

297 cent study showed that patients who received blood transfusion with threshold hemoglobin below 7 g/dl

298 erative and postoperative complications, and blood transfusion within 30 days of a hysterectomy.

299 he main exposure variable was receipt of any blood transfusion within 72 hours after surgery.

300 rs, organ space surgical site infection, and blood transfusion within 72 hours of surgery carried the